324 related articles for article (PubMed ID: 30891751)
1. Challenges in the treatment of psoriasis with biologics: vaccination, history of malignancy, human immunodeficiency virus (HIV) infection, and pediatric psoriasis.
Plachouri KM; Georgiou S
Int J Dermatol; 2019 Sep; 58(9):1008-1013. PubMed ID: 30891751
[TBL] [Abstract][Full Text] [Related]
2. Special aspects of biologics treatment in psoriasis: management in pregnancy, lactation, surgery, renal impairment, hepatitis and tuberculosis.
Plachouri KM; Georgiou S
J Dermatolog Treat; 2019 Nov; 30(7):668-673. PubMed ID: 30428753
[No Abstract] [Full Text] [Related]
3. The risk of malignancy or progression of existing malignancy in patients with psoriasis treated with biologics: case report and review of the literature.
Patel S; Patel T; Kerdel FA
Int J Dermatol; 2016 May; 55(5):487-93. PubMed ID: 26711080
[TBL] [Abstract][Full Text] [Related]
4. Management of pediatric plaque psoriasis using biologics.
Lansang P; Bergman JN; Fiorillo L; Joseph M; Lara-Corrales I; Marcoux D; McCuaig C; Pope E; Prajapati VH; Li SZJ; Landells I
J Am Acad Dermatol; 2020 Jan; 82(1):213-221. PubMed ID: 31150699
[TBL] [Abstract][Full Text] [Related]
5. Current biological therapies for use in HIV-positive patients with psoriasis: case report of gesulkumab used and review.
Bartos G; Cline A; Beroukhim K; Burrall BA; Feldman SR
Dermatol Online J; 2018 Nov; 24(11):. PubMed ID: 30695971
[TBL] [Abstract][Full Text] [Related]
6. From conventional to cutting edge: the new era of biologics in treatment of psoriasis.
Tzu J; Kerdel F
Dermatol Ther; 2008; 21(2):131-41. PubMed ID: 18394087
[TBL] [Abstract][Full Text] [Related]
7. Psoriasis Trends and Practice Gaps.
Gottlieb AB; Greb JE; Goldminz AM
Dermatol Clin; 2016 Jul; 34(3):235-42. PubMed ID: 27363878
[TBL] [Abstract][Full Text] [Related]
8. Proposal for long-term protocols after Psoriasis Area and Severity Index clear with initial biologic therapy: Happily ever after with or without biologics in psoriasis therapy.
Sano S
J Dermatol; 2017 Oct; 44(10):e234-e235. PubMed ID: 28623843
[No Abstract] [Full Text] [Related]
9. Drug safety of systemic treatments for psoriasis: results from The German Psoriasis Registry PsoBest.
Reich K; Mrowietz U; Radtke MA; Thaci D; Rustenbach SJ; Spehr C; Augustin M
Arch Dermatol Res; 2015 Dec; 307(10):875-83. PubMed ID: 26358263
[TBL] [Abstract][Full Text] [Related]
10. Biologics in pediatric psoriasis - efficacy and safety.
Dogra S; Mahajan R
Expert Opin Drug Saf; 2018 Jan; 17(1):9-16. PubMed ID: 29022425
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of Biologic and Conventional Systemic Therapies in Adults with Chronic Plaque Psoriasis in Daily Practice: A Systematic Review.
Zweegers J; Otero ME; van den Reek JM; van Lümig PP; Driessen RJ; Kievit W; Seyger MM; van de Kerkhof PC; de Jong EM
Acta Derm Venereol; 2016 May; 96(4):453-8. PubMed ID: 26537336
[TBL] [Abstract][Full Text] [Related]
12. Geographic Variations in Biologic Therapy and Disease Characteristics: A Pilot-Study in the Corrona Psoriasis Registry.
Enos CW; O'Connell KA; Harrison RW; McLean RR; Dude B; Van Voorhees AS
J Drugs Dermatol; 2020 Nov; 19(11):1119-1122. PubMed ID: 33196741
[No Abstract] [Full Text] [Related]
13. Biologics for psoriasis: more drugs, new patient categories, but fresh challenges for clinical dermatologists.
Pink AE; Smith CH
Br J Dermatol; 2017 Jul; 177(1):7-8. PubMed ID: 28731243
[No Abstract] [Full Text] [Related]
14. Combining biologic therapies with other systemic treatments in psoriasis: evidence-based, best-practice recommendations from the Medical Board of the National Psoriasis Foundation.
Armstrong AW; Bagel J; Van Voorhees AS; Robertson AD; Yamauchi PS
JAMA Dermatol; 2015 Apr; 151(4):432-8. PubMed ID: 25517130
[TBL] [Abstract][Full Text] [Related]
15. Psoriasis in adults and children: Kids are not just little people.
de Moll EH; Chang MW; Strober B
Clin Dermatol; 2016; 34(6):717-723. PubMed ID: 27968931
[TBL] [Abstract][Full Text] [Related]
16. Why Biologic Therapies Sometimes Lose Efficacy.
Strober BE
Semin Cutan Med Surg; 2016 Jun; 35(4 Suppl 4):S78-80. PubMed ID: 27525443
[TBL] [Abstract][Full Text] [Related]
17. The role of biologics and other systemic agents in the treatment of pediatric psoriasis.
Wright NA; Piggott CD; Eichenfield LF
Semin Cutan Med Surg; 2010 Mar; 29(1):20-7. PubMed ID: 20430304
[No Abstract] [Full Text] [Related]
18. Biologic and Conventional Systemic Therapies Show Similar Safety and Efficacy in Elderly and Adult Patients With Moderate to Severe Psoriasis.
Garber C; Plotnikova N; Au SC; Sorensen EP; Gottlieb A
J Drugs Dermatol; 2015 Aug; 14(8):846-52. PubMed ID: 26267729
[TBL] [Abstract][Full Text] [Related]
19. Principles of biological therapy in psoriasis.
Caca Biljanovska N; V'lckova Laskoska M
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2013; 34(1):143-53. PubMed ID: 23928807
[TBL] [Abstract][Full Text] [Related]
20. Psoriasis treatment in HIV-positive patients: a systematic review of systemic immunosuppressive therapies.
Nakamura M; Abrouk M; Farahnik B; Zhu TH; Bhutani T
Cutis; 2018 Jan; 101(1):38;42;56. PubMed ID: 29529104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
